Relapsed/Refractory Chronic Lymphocytic Leukemia or Relapsed/Refractory Non-Hodgkin’s Lymphomas

People with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) or relapse/refractory non-hodgkin’s lymphomas are asked to participate in a research study being conducted by the Montefiore Medical Center.

You may be eligible to participate in this study if you:

• Are at least ≥18 years of age
• Have a diagnosis of R/R CLL or other B-cell neoplasms
• Have an ability to swallow and retain capsules and/or tablets

You may not participate in this study if you:

• Have received chemotherapy, immunotherapy, radiotherapy, or any other investigational therapy within 21 days prior to study treatment
• Have documented or known bleeding disorder
• Have poorly controlled diabetes mellitus
• Have significant cardiovascular disease
• Have history of HIV disease or active hepatitis B or C infection
• Are pregnant or breast-feeding women

Contact Information
Rikin Gandhi, Study Coordinator
Phone: (718) 862-8840 Ext. 451
Email: RIKIN.GANDHI@EINSTEINMED.EDU

23-06-008